MacroGenics Inc (NASDAQ:MGNX)

35.27
Delayed Data
As of Jul 02
 +0.09 / +0.26%
Today’s Change
17.31
Today|||52-Week Range
39.90
+0.57%
Year-to-Date

Today’s Trading

Previous close35.18
Today’s open35.21
Day’s range34.68 - 35.48
Volume94,857
Average volume (3 months)224,012
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-14,332.99%
Earnings growth (this year)+117.14%
Earnings growth (next 5 years)--
Revenue growth (last year)-17.64%
P/E ratio102.1
Price/Sales20.09
Price/Book8.76

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.03-0.67%
ITCIIntra-Cellular Thera...-0.31-0.99%
HRTXHeron Therapeutics I...-0.65-2.11%
PDLIPDL BioPharma Inc-0.28-4.37%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$47.8M
Annual profit (last year)-$38.3M
Net profit margin-80.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers